Evaluating Circulating Tumor DNA (ctdna) As a Prognostic Biomarker Utilizing a Tissue-Free Epigenomic Assay in Early-Stage Triple Negative Breast Cancer (TNBC)
CANCER RESEARCH（2024）
Key words
Cancer Genomics,Intratumor Heterogeneity
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined